Allegion enters its July 23 earnings print with an unusual combination: short interest climbing at its fastest monthly pace in months, analyst targets drifting lower across the board, and yet options traders sitting unusually relaxed. The tension between a rebuilding bear thesis and subdued hedging activity is the week's defining feature.
The short positioning story deserves attention. Short interest has risen 19% over the past month to 4.9% of the free float — still not extreme, but the rate of change is notable. Over the past week alone, shorts added roughly 3%, reversing modest declines earlier in the month. The ORTEX short score has ticked up to 42.8 from around 40 a week ago, consistent with incremental pressure building rather than a sudden capitulation. What makes this less alarming is the lending market itself: borrow availability is running at 813%, well above the year's tightest reading of 588% (hit on June 15), and the cost to borrow has fallen 27% over the past month to just 0.46% annually. The short base is growing, but there is no squeeze dynamic — shares remain easy and cheap to borrow.
Options traders are sending a contrarian signal. The put/call ratio is running at 0.25, well below its 20-day average of 0.31 and close to the low end of its year-long range of 0.07–0.65. The z-score of -0.48 confirms the reading is modestly below normal rather than at an extreme, but the directional message is clear: options buyers are positioned for upside, or at minimum are not hedging against the downside into earnings. That stands in direct contrast to what short-sellers are doing in the equity lending market.
The Street has been in a sustained target-cutting mode since the start of the year. Morgan Stanley lowered its target to $142 in early June while holding Equal-Weight. JP Morgan downgraded outright to Neutral in May, trimming its target to $150 from $170. BofA, Barclays, and Wells Fargo each cut targets in April following the Q1 miss, which sent the stock down 7.4% on the day and 10.9% over the subsequent week. The consensus now sits at Hold, with a mean target of around $165 — roughly 21% above the current price of $136.63. That gap is wide enough to suggest the Street sees recovery potential, but not wide enough to prompt upgrades. The forward PE of 14.6x and EV/EBITDA of 11.8x have both ticked higher over the past week as the stock partially recovered from a 2.8% weekly decline, though both multiples remain below mid-year levels. Factor scores tell a mixed story: the 12-month forward EPS growth rank is strong at the 85th percentile, while the short score rank (27th percentile) and DTC rank (17th) reflect the still-manageable but building short base.
Peer context adds some texture. AOS fell 3.6% on the week, SSD dropped 5.9%, and MAS shed 6.0% — all underperforming ALLE's 2.8% weekly decline. HAYW fared worst in the group, down 6.2%. The relative resilience is modest, but it does suggest the stock is not carrying disproportionate sector risk heading into the print.
What to watch on July 23 is whether management addresses the Americas residential weakness that has driven repeated target cuts — the prior Q1 release produced the sharpest single-day reaction in recent history, and the combination of a rebuilding short base and an unusually unconcerned options market going into the print makes the setup more charged than a plain-vanilla industrial earnings week.
See the live data behind this article on ORTEX.
Open ALLE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
